IRIS Accounts Production v25.3.0.601 11806226 director 1.3.24 28.2.25 28.2.25 false true false false false true false Ordinary £1 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh118062262024-02-29118062262025-02-28118062262024-03-012025-02-28118062262023-02-28118062262023-03-012024-02-29118062262024-02-2911806226ns15:EnglandWales2024-03-012025-02-2811806226ns14:PoundSterling2024-03-012025-02-2811806226ns10:Director12024-03-012025-02-2811806226ns10:PrivateLimitedCompanyLtd2024-03-012025-02-2811806226ns10:SmallEntities2024-03-012025-02-2811806226ns10:AuditExempt-NoAccountantsReport2024-03-012025-02-2811806226ns10:SmallCompaniesRegimeForDirectorsReport2024-03-012025-02-2811806226ns10:SmallCompaniesRegimeForAccounts2024-03-012025-02-2811806226ns10:FullAccounts2024-03-012025-02-281180622612024-03-012025-02-2811806226ns10:OrdinaryShareClass12024-03-012025-02-2811806226ns10:RegisteredOffice2024-03-012025-02-2811806226ns5:CurrentFinancialInstruments2025-02-2811806226ns5:CurrentFinancialInstruments2024-02-2911806226ns5:Non-currentFinancialInstruments2025-02-2811806226ns5:Non-currentFinancialInstruments2024-02-2911806226ns5:ShareCapital2025-02-2811806226ns5:ShareCapital2024-02-2911806226ns5:FurtherSpecificReserve3ComponentTotalEquity2025-02-2811806226ns5:FurtherSpecificReserve3ComponentTotalEquity2024-02-2911806226ns5:RetainedEarningsAccumulatedLosses2025-02-2811806226ns5:RetainedEarningsAccumulatedLosses2024-02-2911806226ns5:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2811806226ns5:PatentsTrademarksLicencesConcessionsSimilar2024-03-012025-02-2811806226ns5:PlantMachinery2024-03-012025-02-2811806226ns5:IntangibleAssetsOtherThanGoodwill2025-02-2811806226ns5:PlantMachinery2024-02-2911806226ns5:PlantMachinery2025-02-2811806226ns5:PlantMachinery2024-02-2911806226ns5:CostValuation2024-02-2911806226ns5:AdditionsToInvestments2025-02-2811806226ns5:RevaluationsIncreaseDecreaseInInvestments2025-02-2811806226ns5:CostValuation2025-02-2811806226ns5:WithinOneYearns5:CurrentFinancialInstruments2025-02-2811806226ns5:WithinOneYearns5:CurrentFinancialInstruments2024-02-2911806226ns10:OrdinaryShareClass12025-02-2811806226ns5:FurtherSpecificReserve3ComponentTotalEquity2024-02-29
REGISTERED NUMBER: 11806226 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 28 FEBRUARY 2025

FOR

NOTTINGHAM GYNAECOLOGY LTD

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


NOTTINGHAM GYNAECOLOGY LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 28 FEBRUARY 2025







Director: D Nunns





Registered office: 10 Stadium Business Court
Millennium Way
Pride Park
Derby
Derbyshire
DE24 8HP





Registered number: 11806226 (England and Wales)





Accountants: TC Group
10 Stadium Business Court
Millennium Way
Pride Park
Derby
Derbyshire
DE24 8HP

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

BALANCE SHEET
28 FEBRUARY 2025

2025 2024
Notes £ £
Fixed assets
Intangible assets 4 499 -
Tangible assets 5 91,753 35,213
Investments 6 94,324 52,909
186,576 88,122

Current assets
Debtors 7 164,502 52,753
Cash at bank 86,136 70,348
250,638 123,101
Creditors
Amounts falling due within one year 8 (62,252 ) (59,098 )
Net current assets 188,386 64,003
Total assets less current liabilities 374,962 152,125

Creditors
Amounts falling due after more than one
year

9

(73,684

)

-

Provisions for liabilities (1,089 ) -
Net assets 300,189 152,125

Capital and reserves
Called up share capital 11 100 100
Fair value reserve 12 8,235 2,909
Retained earnings 291,854 149,116
Shareholders' funds 300,189 152,125

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

BALANCE SHEET - continued
28 FEBRUARY 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 21 October 2025 and were signed by:





D Nunns - Director


NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2025

1. STATUTORY INFORMATION

Nottingham Gynaecology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Intangibles are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£
Cost
Additions 499
At 28 February 2025 499
Net book value
At 28 February 2025 499

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£
Cost
At 1 March 2024 82,623
Additions 119,260
Disposals (76,175 )
At 28 February 2025 125,708
Depreciation
At 1 March 2024 47,410
Charge for year 39,608
Eliminated on disposal (53,063 )
At 28 February 2025 33,955
Net book value
At 28 February 2025 91,753
At 29 February 2024 35,213

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2025

6. FIXED ASSET INVESTMENTS
Other
investments
£
Cost or valuation
At 1 March 2024 52,909
Additions 35,000
Revaluations 6,415
At 28 February 2025 94,324
Net book value
At 28 February 2025 94,324
At 29 February 2024 52,909

Cost or valuation at 28 February 2025 is represented by:

Other
investments
£
Valuation in 2025 94,324

If fixed asset investments had not been revalued they would have been included at the following historical cost:

2025 2024
£ £
Cost 50,000 50,000

Fixed asset investments were valued on an open market basis on 28 February 2025 by Novia and Meteor investments .

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Trade debtors 84,710 30,305
Other debtors 79,792 22,448
164,502 52,753

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Hire purchase contracts 14,777 43,549
Taxation and social security 45,125 13,574
Other creditors 2,350 1,975
62,252 59,098

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2025

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£ £
Hire purchase contracts 73,684 -

10. SECURED DEBTS

The following secured debts are included within creditors:

2025 2024
£ £
Hire purchase contracts 88,461 43,549

Amounts owed under Hire Purchase contracts are secured against the asset to which they relate.

11. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £ £
100 Ordinary £1 £1 100 100

12. RESERVES
Fair value
reserve
£
At 1 March 2024 2,909
Investment fair value uplift 5,733
reserve (407 )

At 28 February 2025 8,235

13. OTHER FINANCIAL COMMITMENTS

The company has entered into a lease agreement for a Mini Cooper vehicle. As at the reporting date, the outstanding commitment under this lease is £11,624.

14. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 28 February 2025 and 29 February 2024:

2025 2024
£ £
**UNKNOWN DIRECTOR 1**
Balance outstanding at start of year 20,523 89,228
Amounts advanced 74,538 21,607
Amounts repaid (21,312 ) (90,312 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 73,749 20,523

NOTTINGHAM GYNAECOLOGY LTD (REGISTERED NUMBER: 11806226)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2025

14. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES - continued

The overdrawn Director Loan Account was cleared in full after the year end, but before the date of these Reports.